Abstract
Rapid reestablishment of infarct vessel patency and microvascular flow provides the best opportunity for minimizing mortality in the patient post myocardial infarction (MI). Early infarct artery patency can be restored by thrombolysis, primary angioplasty, or facilitated percutaneous coronary intervention (PCI). In comparative studies, primary angioplasty offers a greater mortality benefit than thrombolysis in patients with acute MI. Short‐term rates of mortality and stroke were significantly lower in patients receiving primary angioplasty compared with thrombolysis, as was the risk of nonfatal reinfarction. The timing of reperfusion therapy after symptom onset affects outcomes. Patients presenting >3 h after symptom onset are likely to benefit more from PCI than from thrombolysis. Nevertheless, PCI should be performed as soon as possible for optimal results. If PCI is to be delayed, then immediate thrombolysis is likely to be as effective as PCI. Registry data indicate that reperfusion for acute MI is currently underused, with different techniques frequently misapplied. Outcomes tend to be better at centers that perform a high volume of reperfusion procedures, partly due to shorter treatment delays. Facilitated PCI combines fibrinolytic therapy with angioplasty. It is designed to promote very early patency in those who respond to drug therapy, with very high final patency rates assured by angioplasty. Clinical trials have generally found facilitated PCI to be more efficacious than thrombolysis alone. Rescue PCI in cases of failed fibrinolysis is associated with a modest mortality benefit compared with conservative treatment. Myocardial injury following reperfusion after ischemia can limit the benefits of PCI and fibrinolysis; however, strategies for minimizing reperfusion injury have not yet shown clinical efficacy.
Keywords: thrombolysis, primary angioplasty, facilitated percutaneous coronary intervention, reperfusion injury
Full Text
The Full Text of this article is available as a PDF (902.5 KB).
References
- 1. Keeley EC, Boura JA, Grines CL: Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials. Lancet 2003; 361: 13–20 [DOI] [PubMed] [Google Scholar]
- 2. Grzybowski M, Clements EA, Parsons L, Welch R, Tintinalli AT, Ross MA, Zalenski RJ: Mortality benefit of immediate revascularization of acute ST‐segment elevation myocardial infarction in patients with contraindications to thrombolytic therapy: A propensity analysis. J Am Med Assoc 2003; 290: 1891–1898 [DOI] [PubMed] [Google Scholar]
- 3. Zijlstra F, Patel A, Jones M, Grines CL, Ellis S, Garcia E, Grinfeld L, Gibbons RJ, Ribeiro EE, Ribichini F, Granger C, Akhras F, Weaver WD, Simes RJ: Clinical characteristics and outcome of patients with early (<2 h), intermediate (2–4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur Heart J 2002; 23: 550–557 [DOI] [PubMed] [Google Scholar]
- 4. Widimsky P, Budesinsky T, Vorac D, Groch L, Zelizko M, Aschermann M, Branny M, Stasek J, Formanek P; PRAGUE Study Group Investigators : Long distance transport for primary angioplasty vs. immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial—PRAGUE‐2. Eur Heart J 2003; 24: 94–104 [DOI] [PubMed] [Google Scholar]
- 5. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC Jr, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK: American College of Cardiology; American Heart Association Task Force on Practice Guidelines; Canadian Cardiovascular Society: ACC/AHA guidelines for the management of patients with ST‐elevation myocardial infarction—executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004; 110: 588–636 [DOI] [PubMed] [Google Scholar]
- 6. De Luca G, Suryapranata H, Ottervanger JP, Antman EM: Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: Every minute of delay counts. Circulation 2004; 109: 1223–1225 [DOI] [PubMed] [Google Scholar]
- 7. Cannon CP, Gibson CM, Lambrew CT, Shoultz DA, Levy D, French WJ, Gore JM, Weaver WD, Rogers WJ, Tiefenbrunn AJ: Relationship of symptom‐onset‐to‐balloon time and door‐to‐balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. J Am Med Assoc 2000; 283: 2941–2947 [DOI] [PubMed] [Google Scholar]
- 8. Angeja BG, Gibson CM, Chin R, Frederick PD, Every NR, Ross AM, Stone GW, Barron HV; Participants in the National Registry of Myocardial Infarction 2–3: Predictors of door‐to‐balloon delay in primary angioplasty. Am J Cardiol 2002; 89: 1156–1161 [DOI] [PubMed] [Google Scholar]
- 9. Nallamothu BK, Bates ER: Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: Is timing (almost) everything? Am J Cardiol 2003; 92: 824–826 [DOI] [PubMed] [Google Scholar]
- 10. Kent DM, Schmid CH, Lau J, Selker HP: Is primary angioplasty for some as good as primary angioplasty for all? J Gen Intern Med 2002; 17: 887–894 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Barron HV, Bowlby LJ, Breen T, Rogers WJ, Canto JG, Zhang Y, Tiefenbrunn AJ, Weaver WD: Use of reperfusion therapy for acute myocardial infarction in the United States: Data from the National Registry of Myocardial Infarction 2. Circulation 1998; 97: 1150–1156 [DOI] [PubMed] [Google Scholar]
- 12. Eagle KA, Goodman SG, Avezum A, Budaj A, Sullivan CM, Lopez‐Sendon J; GRACE Investigators : Practice variation and missed opportunities for reperfusion in ST‐segment‐elevation myocardial infarction: Findings from the Global Registry of Acute Coronary Events (GRACE). Lancet 2002; 359: 373–377 [DOI] [PubMed] [Google Scholar]
- 13. Magid DJ, Calonge BN, Rumsfeld JS, Canto JG, Frederick PD, Every NR, Barron HV; National Registry of Myocardial Infarction 2 and 3 Investigators : Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs. thrombolytic therapy. J Am Med Assoc 2000; 284: 3131–3138 [DOI] [PubMed] [Google Scholar]
- 14. Ross AM, Coyne KS, Reiner JS, Greenhouse SW, Fink C, Frey A, Moreyra E, Traboulsi M, Racine N, Riba AL, Thompson MA, Rohrbeck S, Lundergan CF: A randomized trial comparing primary angioplasty with a strategy of short‐acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: The PACT trial. PACT investigators. Plasminogen‐activator Angioplasty Compatibility Trial. J Am Coll Cardiol 1999; 34: 1954–1962 [DOI] [PubMed] [Google Scholar]
- 15. Scheller B, Hennen B, Hammer B, Walle J, Hofer C, Hilpert V, Winter H, Nickenig G, Bohm M; SIAM III Study Group : Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction. J Am Coll Cardiol 2003; 42: 634–641 [DOI] [PubMed] [Google Scholar]
- 16. Le May M: Combined Angioplasty and Pharmacological Intervention vs. Thrombolytics Alone in Acute Myocardial Infarction (CAPITAL AMI). Presented at: 53rd Annual Scientific Sessions of the American College of Cardiology; March 7, 2004; New Orleans, La.
- 17. Thiele H, Engelmann L, Elsner K, Kappl MJ, Storch WH, Rahimi K, Hartmann A, Pfeiffer D, Kneissl GD, Schneider D, Moller T, Heberling HJ, Weise I, Schuler G: Comparison of pre‐hospital combination‐fibrinolysis plus conventional care with pre‐hospital combination‐fibrinolysis plus facilitated percutaneous coronary intervention in acute myocardial infarction. Eur Heart J 2005; 26: 1956–1963 [DOI] [PubMed] [Google Scholar]
- 18. Fernandez‐Avilés F, Alonso JJ, Castro‐Beiras A, Goicolea J, Blanco J, Alonso J, Lopez‐Mesa J, Diaz‐Llera L, Vazquez N, Hernandez R, Perez A, Moreu J; The GRACIA‐2 Investigators: Primary Optimal PCI Versus Facilitated Intervention (Tenecteplase Plus Stenting) in Patients with ST‐Elevated Acute Myocardial Infarction: GRACIA‐2 Randomised Trial. Circulation 2003; 108: IV–468 [Google Scholar]
- 19. Fernandez‐Avilés F, Alonso JJ, Castro‐Beiras A, Goicolea J, Blanco J, Alonso J, Lopez‐Mesa J, Diaz‐Llera L, Vazquez N, Hernandez R, Perez A, Moreu J; The GRACIA‐2 Investigators: Primary Angioplasty versus Facilitated Intervention (Tenecteplase plus Stenting) in Patients With ST Elevated Acute Myocardial Infarction: Final Results of the GRACIA‐2 Trial. Presented at: 53rd Annual Scientific Sessions of the American College of Cardiology, March 9, 2004, New Orleans, La.
- 20. Kastrati A, Mehilli J, Schlotterbeck K, Dotzer F, Dirschinger J, Schmitt C, Nekolla SG, Seyfarth M, Martinoff S, Markwardt C, Clermont G, Gerbig HW, Leiss J, Schwaiger M, Schomig A; Bavarian Reperfusion Alternatives Evaluation (BRAVE) Study Investigators : Early administration of reteplase plus abciximab vs. abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: A randomized controlled trial. J Am Med Assoc 2004; 291: 947–954 [DOI] [PubMed] [Google Scholar]
- 21. Ellis SG, Armstrong P, Betriu A, Brodie B, Herrmann H, Montalescot G, Neumann FJ, Smith JJ, Topol E, Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events Investigators : Facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention: Design and rationale of the Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events (FINESSE) trial. Am Heart J 2004; 147: E16 [DOI] [PubMed] [Google Scholar]
- 22. Ellis SG, Da Silva ER, Spaulding CM, Nobuyoshi M, Weiner B, Talley JD: Review of immediate angioplasty after fibrinolytic therapy for acute myocardial infarction: Insights from the RESCUE I, RESCUE II, and other contemporary clinical experiences. Am Heart J 2000; 139: 1046–1053 [DOI] [PubMed] [Google Scholar]
- 23. Sutton AG, Campbell PG, Graham R, Price DJ, Gray JC, Grech ED, Hall JA, Harcombe AA, Wright RA, Smith RH, Murphy JJ, Shyam‐Sundar A, Stewart MJ, Davies A, Linker NJ, de Belder MA: A randomized trial of rescue angioplasty versus a conservative approach for failed fibrinolysis in ST‐segment elevation myocardial infarction: The Middlesbrough Early Revascularization to Limit INfarction (MERLIN) trial. J Am Coll Cardiol 2004; 44: 287–296 [DOI] [PubMed] [Google Scholar]
- 24. Gershlick A: REACT: Rescue Angioplasty versus Conservative Therapy of Repeat Thrombolysis. Presented at: American Heart Association 2004 Annual Scientific Sessions; November 7–10, 2004; New Orleans, La.
- 25. Verma S, Fedak PW, Weisel RD, Butany J, Rao V, Maitland A, Li RK, Dhillon B, Yau TM: Fundamentals of reperfusion injury for the clinical cardiologist. Circulation 2002; 105: 2332–2336 [DOI] [PubMed] [Google Scholar]
- 26. Ikeda N, Yasu T, Kubo N, Hashimoto S, Tsuruya Y, Fujii M, Kawakami M, Saito M: Nicorandil versus isosorbide dinitrate as adjunctive treatment to direct balloon angioplasty in acute myocardial infarction. Heart 2004; 90: 181–185 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Mehta SR, Yusuf S, Diaz R, Zhu J, Pais P, Xavier D, Paolasso E, Ahmed R, Xie C, Kazmi K, Tai J, Orlandini A, Pogue J, Liu L; CREATE‐ECLA Trial Group Investigators : Effect of glucose‐insulin‐potassium infusion on mortality in patients with acute ST‐segment elevation myocardial infarction: The CREATE‐ECLA randomized controlled trial. J Am Med Assoc 2005; 293: 437–446 [DOI] [PubMed] [Google Scholar]
- 28. Stone GW, Webb J, Cox DA, Brodie BR, Qureshi M, Kalynych A, Turco M, Schultheiss HP, Dulas D, Rutherford BD, Antoniucci D, Krucoff MW, Gibbons RJ, Jones D, Lansky AJ, Mehran R, Enhanced Myocardial Efficacy and Recovery by Aspiration of Liberated Debris (EMERALD) Investigators : Distal microcirculatory protection during percutaneous coronary intervention in acute ST‐segment elevation myocardial infarction: A randomized controlled trial. J Am Med Assoc 2005; 293: 1063–1072 [DOI] [PubMed] [Google Scholar]
- 29. Ali A: AIMI: Angio Jet Rheolytic Thrombectomy In Patients Undergoing Primary Angioplasty for Acute Myocardial Infarction. Presented at: Transcatheter Cardiovascular Therapeutics 2004 Meeting; September 27, 2004; Washington, D.C.
- 30. O'Neill WW: COOL‐MI: Cooling as an Adjunctive Therapy to Percutaneous Intervention in Patients With Acute Myocardial Infarction. Presented at: TCT 2003: 15th Annual Transcatheter Cardiovascular Therapeutics; September 16, 2003; Washington, D.C.
- 31. French WJ: Trends in acute myocardial infarction management: Use of the National Registry of Myocardial Infarction in quality improvement. Am J Cardiol 2000; 85: 5B–9B [DOI] [PubMed] [Google Scholar]
- 32. Rogers WJ, Canto JG, Lambrew CT, Tiefenbrunn AJ, Kinkaid B, Shoultz DA, Frederick PD, Every N: Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: The National Registry of Myocardial Infarction 1,2 and 3. J Am Coll Cardiol 2000; 36: 2056–2063 [DOI] [PubMed] [Google Scholar]